CSPC Innovation Pharmaceutical Co., Ltd.
300765.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.77B
Close$
$-6.81
114.4% downside
Current Fair Value
114.4% downsideOvervalued by 114.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $63.77 Billion |
|---|---|
| Enterprise Value | $62.34 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | -0.03 |
| Outstanding Shares | 1,392,592,719 |
Return
| Return on Equity | 25.98% |
|---|---|
| Return on Assets | 11.75% |
| Return on Invested Capital | 24.90% |
Valuation & Multiples
| P/E Ratio | 61.55 |
|---|---|
| PEG | 1.12 |
| Price to Sales | 15.77 |
| Price to Book Ratio | 15.77 |
| Enterprise Value to Revenue | 14.34 |
| Enterprise Value to EBIT | 51.81 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$2.58 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$2.62 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CSPC Innovation Pharmaceutical Co., Ltd.
2,369 employees
CEO: Bing Yao Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company funct...